CD24 is a Potential Biomarker for Prognosis in Human Breast Carcinoma

Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
Xuan JingChongyang Han

Abstract

CD24 is a highly glycosylated mucin-like antigen on the cell surface, which has recently emerged as a novel oncogene and metastasis promoter. We performed bioinformatics analysis to investigate whether CD24 can serve as a prognostic indicator in breast cancer. CD24 expression was assessed using SAGE Genie tools and Oncomine analysis. The PrognoScan database, Kaplan-Meier Plotter, and bc-GenExMiner were used to identify the prognostic roles of CD24 in breast cancer. We found that CD24 was more frequently overexpressed in breast cancer than in normal breast tissue and correlated with worse prognosis. Meanwhile, high CD24 expression was associated with increased risk of HER2, basal-like, triple-negative breast cancer, and higher Scarff-Bloom-Richardson grade. Data mining in multiple big databases confirmed a positive correlation between CD24 mRNA expression and SDC1 mRNA expression in breast cancer tissue. Our findings suggest that CD24 overexpression is more common in breast cancer than in corresponding normal tissue. In addition, CD24 and SDC1 can serve as prognostic indicators for breast cancer. However, large-scale and comprehensive research is needed to further confirm these results.

Citations

Mar 10, 2020·Journal of the Chinese Medical Association : JCMA·Ji-Lin Chen, Ling-Ming Tseng
Mar 20, 2020·Current Pharmaceutical Design·Zhi-Xiang YuanJuchun Lin
Oct 4, 2020·Molecular Biology Reports·Haotian LuLing Li
Dec 19, 2020·Open Medicine·Haotian LuYing Liu
Jun 25, 2020·Current Gene Therapy·Yang-Hong NiWei Wang
Mar 17, 2020·Pathology, Research and Practice·Nazila Fathi MaroufiMohammad Nouri
May 7, 2021·ImmunoTargets and Therapy·Ning XuAlla Dolnikov
Jun 20, 2021·Molecular Biology Reports·Xinjian QuWen Wen
Jul 3, 2021·Journal of Basic and Clinical Physiology and Pharmacology·Aguslina KirtishantiAristika Dinaryanti

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.